S

SBFM

Sunshine Biopharma Inc

1.55

0.08+5.44%
After Hours: 1.511  -0.04  -2.52%19:40 04/24 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Assets

30.56M

27.35M

29.24M

2.20M

1.05M

Total Current Assets

25.97M

24.89M

27.31M

2.20M

1.03M

Total Non Current Assets

4.59M

2.46M

1.93M

7.06K

19.53K

Total Liabilities

7.06M

6.14M

7.62M

1.99M

2.00M

Total Current Liabilities

6.31M

5.55M

6.93M

91.23K

1.05M

Total Non Current Liabilities

744.73K

587.76K

685.27K

1.90M

949.00K

Total Equity

23.50M

21.21M

21.63M

211.66K

-954.84K

Total Stockholders Equity

23.50M

21.21M

21.63M

211.66K

-954.84K

Minority Interest

--

--

--

--

--

Total Liabilities & Shareholders Equity

30.56M

27.35M

29.24M

2.20M

1.05M

Total Common Shares Outstanding

2.58M

14.01K

11.29K

1.30K

870

Total Preferred Shares Outstanding

130.00K

10.00K

10.00K

1.00M

1.00M